News | April 12, 2022
Wacker, CordenPharma to produce mRNA vaccines for Germany
Both companies have been selected for stand-by production by German government
Both companies have been selected for stand-by production by German government
The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
